Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Towa Pharmaceutical

Market Cap: JP¥128.0b

Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.

Pharvaris

Market Cap: US$875.7m

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Avadel Pharmaceuticals

Market Cap: US$873.6m

Operates as a biopharmaceutical company in the United States.

GNI Group

Market Cap: JP¥124.3b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Intellia Therapeutics

Market Cap: US$816.2m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

LENZ Therapeutics

Market Cap: US$815.1m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

Ardelyx

Market Cap: US$811.1m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Zymeworks

Market Cap: US$783.9m

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

Chong Kun Dang Pharmaceutical

Market Cap: ₩1.1t

Engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally.

CureVac

Market Cap: US$764.4m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Geron

Market Cap: US$764.3m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Praxis Precision Medicines

Market Cap: US$755.7m

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

Nuvation Bio

Market Cap: US$745.2m

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

Nurix Therapeutics

Market Cap: US$730.3m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Oscotec

Market Cap: ₩1.0t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

Rocket Pharmaceuticals

Market Cap: US$712.7m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Strides Pharma Science

Market Cap: ₹61.0b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally.

Bicara Therapeutics

Market Cap: US$711.2m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

TaiMed Biologics

Market Cap: NT$21.4b

A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.

Shilpa Medicare

Market Cap: ₹60.3b

Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, recombinant albumin in India, the United States, Europe, and internationally.

uniQure

Market Cap: US$701.1m

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

Immunome

Market Cap: US$693.5m

A clinical-stage biotechnology company, develops targeted cancer therapies.

Anavex Life Sciences

Market Cap: US$693.2m

A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.

China Shineway Pharmaceutical Group

Market Cap: HK$5.4b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

VISEN Pharmaceuticals

Market Cap: HK$5.3b

A biopharmaceutical company, engages in the research, development, and commercialization of paradigm-shifting endocrine therapies in Hong Kong, Macau, Taiwan, and rest of China.

Trevi Therapeutics

Market Cap: US$656.8m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough conditions targeting the central and peripheral nervous systems.

Curaleaf Holdings

Market Cap: CA$916.4m

Produces and distributes cannabis products in the United States and internationally.

ArriVent BioPharma

Market Cap: US$653.5m

A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

Evolus

Market Cap: US$653.1m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

EirGenix

Market Cap: NT$19.7b

Operates as a contract development and manufacturing company in Taiwan and internationally.

Akebia Therapeutics

Market Cap: US$651.3m

A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

Vir Biotechnology

Market Cap: US$649.7m

A clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.

Takara Bio

Market Cap: JP¥94.3b

Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.

Beijing Konruns PharmaceuticalLtd

Market Cap: CN¥4.6b

Engages in the research and development, production, and sale of pharmaceuticals in China and internationally.

Pharming Group

Market Cap: €569.4m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Basilea Pharmaceutica

Market Cap: CHF 533.1m

Engages in the discovering, developing, and commercializing drugs for bacterial or fungal infections.